{"entity":{"type":"insider","cik":"0001598426","url":"/insider/0001598426","json_url":"/insider/0001598426.json","name":"Aliski William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":12,"first":"2014-02-03","last":"2021-02-23","span_basis":"filed_date"},"name_variants":[{"name":"Aliski William","source":"filing","n_filings":12,"first_seen":"2014-02-03","last_seen":"2021-02-23"}],"transactions":[{"id":4087694,"accession":"0001209191-21-013100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-013100","line_url":"/filing/0001209191-21-013100#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":149.01,"price_display":"149.01","price_state":"stated","total_value":1117575.0,"total_display":"1,117,575.00","total_whole":"1,117,575","shares_owned_after":65704.0,"shares_owned_after_display":"65,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-19","filed_date":"2021-02-23","scope":"insider"},{"id":3046656,"accession":"0001209191-20-048205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-048205","line_url":"/filing/0001209191-20-048205#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":86.57,"price_display":"86.57","price_state":"stated","total_value":432850.0,"total_display":"432,850.00","total_whole":"432,850","shares_owned_after":57018.0,"shares_owned_after_display":"57,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-08-25","scope":"insider"},{"id":2219281,"accession":"0001209191-20-034010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-034010","line_url":"/filing/0001209191-20-034010#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":74.0161,"price_display":"74.02","price_state":"stated","total_value":1480322.0,"total_display":"1,480,322.00","total_whole":"1,480,322","shares_owned_after":70350.0,"shares_owned_after_display":"70,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-06-03","scope":"insider"},{"id":2041008,"accession":"0001209191-20-031055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031055","line_url":"/filing/0001209191-20-031055#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":74.65,"price_display":"74.65","price_state":"stated","total_value":559875.0,"total_display":"559,875.00","total_whole":"559,875","shares_owned_after":47924.0,"shares_owned_after_display":"47,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":6026751,"accession":"0001273636-18-000085","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001273636-18-000085","line_url":"/filing/0001273636-18-000085","is_derivative":false,"issuer_cik":"0001273636","issuer_name":"APPLIED GENETIC TECHNOLOGIES CORP","issuer_ticker":"AGTC","issuer_name_source":null,"issuer_url":"/issuer/0001273636","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":3.246166666666667,"price_display":"3.25","price_state":"stated","total_value":19477.0,"total_display":"19,477.00","total_whole":"19,477","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-18","scope":"insider","n_lines":3},{"id":6296970,"accession":"0001209191-18-061480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061480","line_url":"/filing/0001209191-18-061480#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":49.69,"price_display":"49.69","price_state":"stated","total_value":298140.0,"total_display":"298,140.00","total_whole":"298,140","shares_owned_after":90350.0,"shares_owned_after_display":"90,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-07","scope":"insider"},{"id":6001498,"accession":"0001209191-18-057820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-057820","line_url":"/filing/0001209191-18-057820#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":55.67,"price_display":"55.67","price_state":"stated","total_value":334020.0,"total_display":"334,020.00","total_whole":"334,020","shares_owned_after":96350.0,"shares_owned_after_display":"96,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-11-08","filed_date":"2018-11-08","scope":"insider"},{"id":6560136,"accession":"0001209191-18-054531","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-054531","line_url":"/filing/0001209191-18-054531#line-6","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":73.38,"price_display":"73.38","price_state":"stated","total_value":440280.0,"total_display":"440,280.00","total_whole":"440,280","shares_owned_after":102350.0,"shares_owned_after_display":"102,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-08","filed_date":"2018-10-09","scope":"insider"},{"id":6707202,"accession":"0001209191-18-045878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-045878","line_url":"/filing/0001209191-18-045878#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":76.66,"price_display":"76.66","price_state":"stated","total_value":287475.0,"total_display":"287,475.00","total_whole":"287,475","shares_owned_after":72610.0,"shares_owned_after_display":"72,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-08","scope":"insider"},{"id":6560132,"accession":"0001209191-18-054531","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-054531","line_url":"/filing/0001209191-18-054531#line-5","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stocki","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":650.0,"shares_display":"650","price_per_share":53.97,"price_display":"53.97","price_state":"stated","total_value":35080.5,"total_display":"35,080.50","total_whole":"35,081","shares_owned_after":108350.0,"shares_owned_after_display":"108,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-19","filed_date":"2018-10-09","scope":"insider"},{"id":2617113,"accession":"0001562180-16-003674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-16-003674","line_url":"/filing/0001562180-16-003674","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":78.19333333333333,"price_display":"78.19","price_state":"stated","total_value":469160.0,"total_display":"469,160.00","total_whole":"469,160","shares_owned_after":61985.0,"shares_owned_after_display":"61,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-05","scope":"insider","n_lines":2},{"id":6560129,"accession":"0001209191-18-054531","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-054531","line_url":"/filing/0001209191-18-054531#line-4","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":122.58,"price_display":"122.58","price_state":"stated","total_value":49032.0,"total_display":"49,032.00","total_whole":"49,032","shares_owned_after":109000.0,"shares_owned_after_display":"109,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-27","filed_date":"2018-10-09","scope":"insider"},{"id":6560126,"accession":"0001209191-18-054531","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-054531","line_url":"/filing/0001209191-18-054531#line-3","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":85.94,"price_display":"85.94","price_state":"stated","total_value":171880.0,"total_display":"171,880.00","total_whole":"171,880","shares_owned_after":109400.0,"shares_owned_after_display":"109,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-27","filed_date":"2018-10-09","scope":"insider"},{"id":6560121,"accession":"0001209191-18-054531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-054531","line_url":"/filing/0001209191-18-054531#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":68.65,"price_display":"68.65","price_state":"stated","total_value":720825.0,"total_display":"720,825.00","total_whole":"720,825","shares_owned_after":111400.0,"shares_owned_after_display":"111,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2018-10-09","scope":"insider"},{"id":6420941,"accession":"0001209191-14-073714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-073714","line_url":"/filing/0001209191-14-073714","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":42.15703315,"price_display":"42.16","price_state":"stated","total_value":252942.1989,"total_display":"252,942.20","total_whole":"252,942","shares_owned_after":60010.0,"shares_owned_after_display":"60,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-04","filed_date":"2014-12-08","scope":"insider","n_lines":2},{"id":6521845,"accession":"0001209191-14-006657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-006657","line_url":"/filing/0001209191-14-006657#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001598426","owner_name":"Aliski William","owner_display_name":"Aliski William","owner_url":"/insider/0001598426","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","total_whole":"105,000","shares_owned_after":36903.0,"shares_owned_after_display":"36,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-30","filed_date":"2014-02-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Director","n_filings":11,"first_seen":"2014-02-03","last_seen":"2021-02-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001273636","name":"APPLIED GENETIC TECHNOLOGIES CORP","url":"/issuer/0001273636","role":"Director","n_filings":1,"first_seen":"2018-12-18","last_seen":"2018-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598426","retrieved_at":"2026-08-27T07:07:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}